GlassScriptPhysician profile
Florence C Spitler
NPI 1952381071
$5,565.10
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,328 · 2020: $1,410 · 2021: $1,677 · 2022: $150.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $856.41 | 2019-2022 | |
| Amarin Pharma, INC. | $480.01 | 2019-2021 | |
| Amgen INC. | $454.82 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $445.18 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $361.24 | 2019-2021 | |
| Allergan, INC. | $329.48 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $291.99 | 2019-2022 | |
| Glaxosmithkline, LLC. | $277.00 | 2019-2021 | |
| Esperion Therapeutics, INC. | $254.04 | 2020-2021 | |
| Astellas Pharma US INC | $232.88 | 2019-2021 | |
| Lilly USA, LLC | $223.20 | 2019-2021 | |
| Abbvie INC. | $218.76 | 2019-2022 | |
| Abbott Laboratories | $141.13 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $98.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $85.14 | 2019-2021 |
Show all 42 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florence Spitler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.